Literature DB >> 29474834

Non-immunoglobulin scaffold proteins: Precision tools for studying protein-protein interactions in cancer.

Heather L Martin1, Robert Bedford1, Sophie J Heseltine1, Anna A Tang1, Katarzyna Z Haza1, Ajinkya Rao1, Michael J McPherson1, Darren C Tomlinson2.   

Abstract

Cancer is frequently characterised by dysregulation of the cellular signalling processes that govern proliferation, survival and attachment. Understanding such dysregulation continues to present a challenge given the importance of protein-protein interactions in intracellular processes. Exploring this protein-protein interactome requires novel tools capable of discriminating between highly homologous proteins, individual domains and post-translational modifications. This review examines the potential of scaffold-based binding proteins to fulfil these requirements. It also explores protein-protein interactions in the context of intracellular signalling pathways and cancer, and demonstrates the uses of scaffold proteins as functional moderators, biosensors and imaging reagents. This review also highlights the timeliness and potential to develop international consortia to develop and validate highly specific "proteome" scaffold-based binding protein reagents with the ultimate aim of developing screening tools for studying the interactome.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Affimer; DARPins; Intracellular signalling; Monobody; Protein-protein interaction

Mesh:

Substances:

Year:  2018        PMID: 29474834     DOI: 10.1016/j.nbt.2018.02.008

Source DB:  PubMed          Journal:  N Biotechnol        ISSN: 1871-6784            Impact factor:   5.079


  8 in total

Review 1.  Scaffold Proteins: From Coordinating Signaling Pathways to Metabolic Regulation.

Authors:  Yves Mugabo; Gareth E Lim
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

Review 2.  Modulating protein-protein interaction networks in protein homeostasis.

Authors:  Mengqi Zhong; Gregory M Lee; Eline Sijbesma; Christian Ottmann; Michelle R Arkin
Journal:  Curr Opin Chem Biol       Date:  2019-03-23       Impact factor: 8.822

3.  Studies of the oligomerisation mechanism of a cystatin-based engineered protein scaffold.

Authors:  Matja Zalar; Sowmya Indrakumar; Colin W Levy; Richard B Tunnicliffe; Günther H J Peters; Alexander P Golovanov
Journal:  Sci Rep       Date:  2019-06-21       Impact factor: 4.379

4.  Artificial Scaffold Polypeptides As an Efficient Tool for the Targeted Delivery of Nanostructures In Vitro and In Vivo.

Authors:  V O Shipunova; S M Deyev
Journal:  Acta Naturae       Date:  2022 Jan-Mar       Impact factor: 2.204

5.  The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast Cancer.

Authors:  O D Bragina; S M Deyev; V I Chernov; V M Tolmachev
Journal:  Acta Naturae       Date:  2022 Apr-Jun       Impact factor: 2.204

6.  Tuning SAS-6 architecture with monobodies impairs distinct steps of centriole assembly.

Authors:  Georgios N Hatzopoulos; Tim Kükenshöner; Niccolò Banterle; Tatiana Favez; Isabelle Flückiger; Virginie Hamel; Santiago Andany; Georg E Fantner; Oliver Hantschel; Pierre Gönczy
Journal:  Nat Commun       Date:  2021-06-21       Impact factor: 14.919

7.  ABD-Derived Protein Blockers of Human IL-17 Receptor A as Non-IgG Alternatives for Modulation of IL-17-Dependent Pro-Inflammatory Axis.

Authors:  Marie Hlavničková; Milan Kuchař; Radim Osička; Lucie Vaňková; Hana Petroková; Michal Malý; Jiří Černý; Petr Arenberger; Petr Malý
Journal:  Int J Mol Sci       Date:  2018-10-09       Impact factor: 5.923

8.  Proteomic Analysis of Human Serum for Patients at Different Pathological Stages of Hepatic Fibrosis.

Authors:  Kang Zhao; Jucun Huang; Hongmei Xia; Jianjun Zhang; Liming Liu
Journal:  Biomed Res Int       Date:  2021-11-28       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.